-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of August 16, Buchang Pharmaceutical issued an announcement stating that the drug compound brain peptide ganglioside injection of the holding subsidiary Jilin Tiancheng Pharmaceutical and the drug Guhong injection of the wholly-owned subsidiary Tonghua Guhong Pharmaceutical will be held in December 2021.
The announcement shows that the compound brain peptide ganglioside injection will have a revenue of 119 million yuan in Heilongjiang in 2020, and the Guhong injection will have a revenue of 126 million yuan in Heilongjiang in 2020, accounting for 0.